Your browser doesn't support javascript.
loading
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
Burska, Agata; Rodríguez-Carrio, Javier; Biesen, Robert; Dik, Willem A; Eloranta, Maija-Leena; Cavalli, Giulio; Visser, Marianne; Boumpas, Dimitrios T; Bertsias, George; Wahren-Herlenius, Marie; Rehwinkel, Jan; Frémond, Marie-Louise; Crow, Mary K; Ronnblom, Lars; Conaghan, P G; Versnel, Marjan; Vital, Ed.
Affiliation
  • Burska A; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, UK.
  • Rodríguez-Carrio J; University of Oviedo, Area of Immunology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Biesen R; Charité University Medicine Berlin, Department of Rheumatology, Berlin, Germany.
  • Dik WA; Erasmus MC, University Medical Center Rotterdam, Laboratory Medical Immunology, Department of Immunology, Rotterdam, Netherlands Immunology, Rotterdam, The Netherlands.
  • Eloranta ML; Uppsala University, Department of Medical Sciences, Rheumatology, Uppsala, Sweden.
  • Cavalli G; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, Vita-Salute San Raffaele University, Milan, Italy.
  • Visser M; EULAR, PARE Patient Research Partners, Amsterdam, Netherlands.
  • Boumpas DT; University of Crete, Medical School, Department of Internal Medicine, Heraklion, Greece.
  • Bertsias G; University of Crete, Medical School, Department of Rheumatology-Clinical Immunology, Heraklion, Greece.
  • Wahren-Herlenius M; University of Crete, Medical School, Department of Rheumatology-Clinical Immunology, Heraklion, Greece.
  • Rehwinkel J; Karolinska Institutet, Division of Rheumatology, Stockholm, Sweden.
  • Frémond ML; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Norway.
  • Crow MK; Medical Research Council Human Immunology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, UK.
  • Ronnblom L; Université de Paris Cité, Hôpital Necker-Enfants Malades, Immuno-Hématologie et Rhumatologie pédiatriques, Paris, France.
  • Conaghan PG; Hospital for Special Surgery, Weill Cornell Medical College, Mary Kirkland Center for Lupus Research, New York, USA.
  • Versnel M; Uppsala University, Department of Medical Sciences, Rheumatology, Uppsala, Sweden.
  • Vital E; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, UK.
RMD Open ; 9(1)2023 03.
Article in En | MEDLINE | ID: mdl-36863752
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / Rheumatic Diseases / Musculoskeletal Diseases Type of study: Diagnostic_studies / Etiology_studies / Systematic_reviews Limits: Humans Language: En Journal: RMD Open Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon Type I / Rheumatic Diseases / Musculoskeletal Diseases Type of study: Diagnostic_studies / Etiology_studies / Systematic_reviews Limits: Humans Language: En Journal: RMD Open Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido